MANAGEMENT OF PORTAL HYPERTENSION AFTER VARICEAL HEMORRHAGE

Acharya, 1993, A prospective randomized study to evaluate propranolol in patients undergoing long-term sclerotherapy, J Hepatol, 19, 291, 10.1016/S0168-8278(05)80585-9 Akriviadis, 1989, Frequent endoscopic variceal sclerotherapy increases risk of complications: Prospective randomized controlled study of two treatment schedules, Dig Dis Sci, 34, 1068, 10.1007/BF01536376 Albillos, 1993, Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats, Gastroenterology, 104, 575, 10.1016/0016-5085(93)90429-G Alexandrino, 1990, Is sclerotherapy the first-choice treatment for oesophageal variceal bleeding in cirrhotic patients? Final report of a randomized clinical trial, J Hepatol, 11, S1, 10.1016/0168-8278(90)91337-V Alexandrino, 1988, Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal hemorrhage, J Hepatol, 7, 175, 10.1016/S0168-8278(88)80480-X Andreani, 1991, Efficacite comparee du propranolol et de sclerose endoscopique de varices oesophagiemes dans la prevention des recidives d'hemorragies digestives au cours des cirrhosis. Etude controlee, Gastroenterol Clin Biol, 15, A215 Aramaki, 1992, Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol, J Hepatol, 15, 48, 10.1016/0168-8278(92)90010-M Avgerinos, 1994, Balloon tamponade technique and efficacy in variceal haemorrhage, Scand J Gastroenterol Suppl, 207, 11, 10.3109/00365529409104188 Avgerinos, 1995, Somatostatin and octreotide in the management of acute variceal hemorrhage, Hepatogastroenterology, 42, 145 Avgerinos, 1991, A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage, J Hepatol, 13, 78, 10.1016/0168-8278(91)90867-B Avgerinos, 1997, Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomized trial, Lancet, 350, 1495, 10.1016/S0140-6736(97)05099-X Bagarani, 1987, Effect of somatostatin in controlling bleeding from esophageal varices, Italian Journal of Surgical Sciences, 17, 21 Barsoum, 1982, Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices, Br J Surg, 69, 76, 10.1002/bjs.1800690206 Baxter, 1994, Somatostatin: An alternative to sclerotherapy?, Scand J Gastroenterol Suppl, 207, 17, 10.3109/00365529409104189 Bendtsen, 1991, Long-term effects of oral propranolol on splanchnic and systemic hemodynamics in patients with cirrhosis and oesophageal varices, Scand J Gastroenterol, 26, 933, 10.3109/00365529108996245 Bendtsen, 1991, Propranolol and hemodynamic responses in cirrhosis, J Hepatol, 13, 144, 10.1016/0168-8278(91)90807-N Bendtsen, 1992, Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis, Gastroenterology, 102, 1017, 10.1016/0016-5085(92)90191-Z Benoit, 1986, Splanchnic hemodynamics in chronic portal hypertension, Semin Liv Dis, 6, 287, 10.1055/s-2008-1040611 Bernard, 1997, Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis, J Hepatol, 26, 312, 10.1016/S0168-8278(97)80047-5 Bertoni, 1990, Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: A randomized pilot study, J Clin Gastroenterol, 12, 364 Besson, 1995, Sclerotherapy with or without octreotide for acute variceal bleeding, N Engl J Med, 333, 555, 10.1056/NEJM199508313330904 Bhargava, 1997, Endoscopic variceal ligation versus endoscopic variceal ligation and endoscopic sclerotherapy: A prospective randomized study [see comments], Am J Gastroenterol, 92, 950 Bhathal, 1985, Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators, J Hepatol, 1, 325, 10.1016/S0168-8278(85)80770-4 Blei, 1986, Isosorbide dinitrate in experimental portal hypertension; a study of factors that modulate the hemodynamic response, Hepatology, 6, 107, 10.1002/hep.1840060120 Blei, 1984, Vasopressin and vasoconstrictors, 377 Blei, 1980, Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic haemodynamics in dogs, Dig Dis Sci, 25, 688, 10.1007/BF01308328 Bomzon, 1994, The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis, Hepatology, 20, 1343, 10.1002/hep.1840200535 Bosch, 1988, Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: Comparison with the effects on portal pressure, Hepatology, 8, 861, 10.1002/hep.1840080427 Bosch, 1984, Measurement of azygos venous blood flow by a continuous thermal dilution technique: An index of blood flow through gastroesophageal collaterals in cirrhosis, Hepatology, 4, 424, 10.1002/hep.1840040312 Bosch, 1989, Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: A placebo-controlled clinical trial, Hepatology, 10, 962, 10.1002/hep.1840100612 Bosch, 1981, Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin, Gastroenterology, 80, 518, 10.1016/0016-5085(81)90014-7 Bosch, 1985, Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis, J Hepatol, 1, 125, 10.1016/S0168-8278(85)80761-3 Bosch, 1984, Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis, Hepatology, 4, 1200, 10.1002/hep.1840040617 Braillon, 1989, Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol, J Hepatol, 9, 312, 10.1016/0168-8278(89)90139-6 Brunati, 1996, Sclerotherapy alone vs. sclerotherapy plus terlipressin vs. sclerotherapy plus octreotide in the treatment of acute variceal hemorrhage: Our experience [abstract], Hepatology, 24, 207A Burroughs, 1995, Pharmacological therapy for portal hypertension: Rationale and results, Semin Gastrointest Dis, 6, 148 Burroughs, 1994, Octreotide in variceal bleeding, Gut, 35, S23, 10.1136/gut.35.3_Suppl.S23 Burroughs, 1983, Randomised, controlled study of transhepatic obliteration of varices and oesophageal stapling transection in uncontrolled variceal haemorrhage, Liver, 3, 122, 10.1111/j.1600-0676.1983.tb00858.x Burroughs, 1983, Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis, N Engl J Med, 309, 1539, 10.1056/NEJM198312223092502 Burroughs, 1992, Prevention of variceal rebleeding, Gastroenterol Clin North Am, 21, 119, 10.1016/S0889-8553(21)00181-3 Burroughs, 1990, Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding [see comments], Gastroenterology, 99, 1388, 10.1016/0016-5085(90)91166-4 Burroughs, 1989, Randomized trial of long-term sclerotherapy for variceal rebleeding using the same protocol to treat rebleeding in all patients. A final report [abstract], Gut, 30, A1506 Cales, 1984, Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol, J Hepatol, 1, 37, 10.1016/S0168-8278(85)80066-0 Caujolle, 1988, Relationship among beta-adrenergic blockade, propranolol concentration and liver function in patients with cirrhosis, Scand J Gastroenterol, 23, 925, 10.3109/00365528809090148 Cerbelaud, 1986, Propranolol et prevention des recidives des ruptures de varice oesophagienne du cirrhotique, Gastroenterol Clin Biol, 10, 18A Cervinka, 1988, Effect of per oral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver, J Int Med Res, 17, 560, 10.1177/030006058901700610 Cioni, 1992, Duplex-Doppler ultrasonography in the evaluation of cirrhotic patients with portal hypertension and in the analysis of their response to drugs, J Gastroenterol Hepatol, 7, 388, 10.1111/j.1440-1746.1992.tb01005.x Colman, 1990, Propranolol in the prevention of variceal hemorrhage in alcoholic cirrhotic patients, Hepatol, 12, 851 Colombato, 1991, Temporal relationship of peripheral vasodilation, plasma volume expansion and the hyperdynamic circulatory state in portal hypertensive rats, Hepatology, 15, 323, 10.1002/hep.1840150224 Colombo, 1989, Beta blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial, Hepatology, 9, 433, 10.1002/hep.1840090315 Conn, 1991, Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial, Hepatology, 13, 902, 10.1002/hep.1840130517 Consolo, 1992, [Theoretical and physiopharmacological bases of the somatostatin treatment in digestive disease.], Minerva Chir, 47, 723 D'Amico, 1995, The treatment of portal hypertension: A meta-analytic review, Hepatology, 22, 332, 10.1002/hep.1840220145 D'Amico, 1999, Pharmacological treatment of portal hypertension: An evidence-based approach, Semin Liver Dis, 19, 475, 10.1055/s-2007-1007133 Dagradi, 1972, The natural history of esophageal varices in patients with alcoholic liver disease: An endoscopic and clinical study, Am J Gastroenterol, 57, 520 De Franchis, 1994, Treatment of bleeding oesophageal varices: A meta-analysis, Scand J Gastroenterol, 207, 29, 10.3109/00365529409104191 De Franchis, 1999, Endoscopic treatments for portal hypertension, Semin Liver Dis, 19, 439, 10.1055/s-2007-1007131 de la Pena, 1999, Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: Prospective randomized trial, Gastrointest Endosc, 49, 417, 10.1016/S0016-5107(99)70036-2 DeDombal, 1986, Prognostic factors in upper G.I. bleeding, Endoscopy, 18, 6S, 10.1055/s-2007-1018418 deFranchis, 1992, Why do varices bleed?, Gastroenterol Clin North Am, 21, 85, 10.1016/S0889-8553(21)00179-5 Dennert, 1997, A prospective evaluation of the endoscopic spectrum of overtube-related esophageal mucosal injury, Gastrointest Endosc, 45, 134, 10.1016/S0016-5107(97)70235-9 Dollet, 1988, Sclerotherapie endoscopique contre propranolol apres hemorrage par rupture de varices oesophagennes chex le cirrhotique [abstract], Gastroenterol Clin Biol, 12, 234 El-Zayadi, 1988, Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease, Gastrointest Endosc, 34, 314, 10.1016/S0016-5107(88)71363-2 Epstein, 1982, Beta-blockers and the kidney, Miner Electrolyte Metab, 8, 237 Eriksson, 1984, Influence of somatostatin on splanchnic hemodynamics in patients with cirrhosis, Clin Physiol, 4, 616, 10.1111/j.1475-097X.1984.tb00639.x Escorsell, 2001, Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension, Gastroenterology, 120, 161, 10.1053/gast.2001.20892 Escorsell, 1998, Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group, J Hepatol, 29, 779, 10.1016/S0168-8278(98)80259-6 Ferayorni, 1996, Drug therapy for portal hypertension: A 5 year review, 68 Flati, 1986, [Somatostatin. Massive upper digestive hemorrhage in portal hypertension, Results of a controlled study] Revista Espagnol de las En Fermedades del Aparato Digestivo, 70, 411 Fleig, 1987, Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: Prospective randomized comparison of propranolol and sclerotherapy, Hepatology, 7, 355, 10.1002/hep.1840070224 Fort, 1990, A randomized trial of terlipressin plus nitroglycerin vs balloon tamponade in the control of acute variceal hemorrhage, Hepatology, 11, 678, 10.1002/hep.1840110423 Freeman, 1989, Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal hemorrhage, J Clin Gastroenterol, 11, 58, 10.1097/00004836-198902000-00014 Frishman, 1982, Nadolol: A new beta-adrenoceptor antagonist, N Engl J Med, 305, 678 Gaiani, 1991, Effect of propranolol on portasystemic collateral circulation in patients with cirrhosis, Hepatology, 14, 824, 10.1002/hep.1840140514 Garcia-Pagan, 1990, Long-term hemodynamic effects of isosorbide 5-monomitrate in patients with cirrhosis and portal hypertension, J Hepatol, 11, 189, 10.1016/0168-8278(90)90112-5 Garcia-Pagan, 1991, Propranolol compared with propranolol plus isosorbide 5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study, Ann Intern Med, 114, 869, 10.7326/0003-4819-114-10-869 Garcia-Pagan, 1990, Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis, Hepatology, 11, 230, 10.1002/hep.1840110212 Garcia-Tsao, 1986, Short-term effects of propranolol on portal venous pressure, Hepatology, 6, 101, 10.1002/hep.1840060119 Garcia-Tsao, 1987, Portal hemodynamics during nitroglycerin administration in cirrhotic subjects, Hepatology, 7, 805, 10.1002/hep.1840070502 Garcia-Tsao, 1985, Portal pressures, presence of gastroesophageal varices and variceal bleeding, Hepatology, 5, 419, 10.1002/hep.1840050313 Garden, 1990, Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients, Gastroenterology, 98, 185, 10.1016/0016-5085(90)91308-S Gatta, 1987, Nadolol for prevention of variceal rebleeding in cirrhosis: A controlled clinical trial, Digestion, 37, 22, 10.1159/000199483 Gerunda, 1990, Nadolol does not reduce early rebleeding in cirrhotics undergoing endoscopic variceal sclerotherapy: A multicenter randomized controlled trial, Hepatology, 12, 988 Gibson, 1986, The hypotensive effect of oral nitroglycerin on portal venous pressure in patients with cirrhotic portal hypertension, J Gastroenterol Hepatol, 1, 201, 10.1111/j.1440-1746.1986.tb00114.x Gimson, 1993, Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices [see comments], Lancet, 342, 391, 10.1016/0140-6736(93)92812-8 Gimson, 1986, A randomized controlled trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage, Hepatology, 6, 410, 10.1002/hep.1840060314 Gines, 1992, Effects of somatostatin on renal function in cirrhosis, Gastroenterology, 103, 1868, 10.1016/0016-5085(92)91446-B Gostout, 1998, Endoscopic esophageal variceal band ligation: How intensively should we ligate? [editorial; comment], Am J Gastroenterol, 93, 135, 10.1111/j.1572-0241.1998.135_1.x Gotzsche, 1995, Somatostatin v placebo in bleeding oesophageal varices: Randomised trial and meta-analysis, BMJ, 310, 1495, 10.1136/bmj.310.6993.1495 Goulis, 1998, Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage, Hepatology, 27, 1207, 10.1002/hep.510270504 Grace, 1990, A hepatologist's view of variceal bleeding, Am J Surg, 160, 26, 10.1016/S0002-9610(05)80864-5 Grace, 1997, Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee, Am J Gastroenterol, 92, 1081 Graham, 1981, The course of patients after variceal hemorrhage, Gastroenterology, 80, 800, 10.1016/0016-5085(81)90144-X Gregory, 1990, Sclerotherapy for actively bleeding esophageal varices in male alcoholics: results of a randomized multicenter clinical trial [abstract], Gastroenterology, 98, AJ3 Groszmann, 1990, Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage, Gastroenterology, 99, 1401, 10.1016/0016-5085(90)91168-6 Groszmann, 1982, Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension, Hepatology, 2, 757, 10.1002/hep.1840020602 Gupta, 1997, Pathophysiology of portal hypertension, Clin Liv Dis, 1, 1, 10.1016/S1089-3261(05)70251-8 Hanisch, 1992, Somatostatin in acute bleeding oesophageal varices. Pharmacology and rationale for use, Drugs, 44, 24, 10.2165/00003495-199200442-00005 Hayes, 1990, Meta-analysis of value of propranolol in prevention of variceal hemorrhage, Lancet, 336, 153, 10.1016/0140-6736(90)91668-Z Hayes, 1988, Effect and mechanism of action of isosorbide-5-mononitrate, Gut, 29, 752, 10.1136/gut.29.6.752 Heikkinen, 1999, Infrarenal endoluminal bifurcated stent graft infected with Listeria monocytogenes, J Vasc Surg, 29, 554, 10.1016/S0741-5214(99)70285-5 Henderson, 1993, Portal hypertension and shunt surgery, Adv Surg, 26, 233 Hoffman, 1990, Adrenergic receptor antagonists, 221 Hosking, 1989, Anorectal varices, haemorrhoids, and portal hypertension, Lancet, 1, 349, 10.1016/S0140-6736(89)91724-8 Hou, 1994, Oesophageal perforation following endoscopic variceal ligation and balloon tamponade, J Gastroenterol Hepatol, 9, 659, 10.1111/j.1440-1746.1994.tb01582.x Hou, 1995, Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial, Hepatology, 21, 1517 Hwang, 1992, A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding, J Hepatol, 16, 320, 10.1016/S0168-8278(05)80663-4 International Octroetide Varices Study Group, 1996, Double blind RCT of 5 day octreotide versus placebo associated with sclerotherapy for trial/failures [abstract], Hepatology, 24, 352A Iwao, 1991, Effect of intraportal nitroglycerin on portosystemic hemodynamics in patients with cirrhosis: Comparison with i.v. route, J Clin Gastroenterol, 13, 424, 10.1097/00004836-199108000-00012 Iwao, 1991, Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis, Hepatology, 13, 124, 10.1002/hep.1840130118 Jaramillo, 1991, Somatostatin versus Sengstaken balloon tamponade for primary haemostasia of bleeding esophageal varices. A randomized pilot study, J Hepatol, 12, 100, 10.1016/0168-8278(91)90917-Z Jenkins, 1985, A prospective randomized controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal hemorrhage, BMJ, 290, 275, 10.1136/bmj.290.6464.275 Jenkins, 1985, Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man, Br J Surg, 72, 1009, 10.1002/bjs.1800721225 Jenkins, 1988, The effect of somatostatin and SMS-201-995 on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension, Fibrinolysis, 2, 48 Jenkins, 1997, A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage, Gut, 41, 526, 10.1136/gut.41.4.526 Jensen, 1993, Initial results of a randomized study of emergency banding vs sclerotherapy for bleeding gastric or esophageal varices, Gastrointest Endosc, 39, 279 Jensen, 1990, Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy, Scand J Gastroenterol, 25, 352, 10.3109/00365529009095498 Jiron, 1985, Relationship between dose, blood level and hemodynamic response in patients with cirrhosis receiving propranolol, Eur J Clin Pharmacol, 28, 353, 10.1007/BF00543337 Johnson, 1993, Complications associated with endoscopic band ligation of esophageal varices [see comments], Gastrointest Endosc, 39, 181, 10.1016/S0016-5107(93)70064-4 Kahn, 1989, Incidence and management of complications after injection sclerotherapy: A ten-year prospective evaluation, Surgery, 105, 160 Kanazawa, 1986, Measurement of azygos blood flow by a continuous thermodilution method in liver disease, Acta Hepatol Jap, 27, 1132, 10.2957/kanzo.27.1132 Kawada, 1993, The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances: Possible involvement of endothelin-1 and NO in the regulation of the sinusoidal tonus, Eur J Biochem, 213, 815, 10.1111/j.1432-1033.1993.tb17824.x Kiire, 1989, Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis, BMJ, 298, 1363, 10.1136/bmj.298.6684.1363 Kong, 1986, Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis, Dig Dis Sci, 31, 1303, 10.1007/BF01299807 Korula, 1985, A prospective randomized controlled trial of chronic esophageal variceal sclerotherapy, Hepatology, 5, 584, 10.1002/hep.1840050410 Koshy, 1989, Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats, Hepatology, 9, 269, 10.1002/hep.1840090218 Kowdley, 1995, Cost-benefit analysis of transjugular intrahepatic portosystemic shunts (TIPS) vs sclerotherapy for management of variceal hemorrhage [abstract], Am J Gastroenterol, 90, 1562 Kravetz, 1989, Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: Influence of the extent of portal-systemic shunting, Hepatology, 9, 808, 10.1002/hep.1840090603 Kravetz, 1984, Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage, Hepatology, 4, 442, 10.1002/hep.1840040315 Kravetz, 1987, Hyposensitivity to vasopressin in a haemorrhaged-transfused rat model of portal hypertension, Gastroenterology, 93, 170, 10.1016/0016-5085(87)90330-1 Kravetz, 1986, Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution, Gastroenterology, 90, 1232, 10.1016/0016-5085(86)90390-2 Kroeger, 1985, Increased portal venous resistance hinders portal pressure reduction during the administration of β-adrenergic blocking agents in a portal hypertensive model, Hepatology, 5, 97, 10.1002/hep.1840050120 Laine, 1993, Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices, Ann Intern Med, 119, 1, 10.7326/0003-4819-119-1-199307010-00001 Laine, 1996, Randomized comparison of ligation versus ligation plus sclerotherapy in patients with bleeding esophageal varices [see comments], Gastroenterology, 110, 529, 10.1053/gast.1996.v110.pm8566601 Larson, 1986, Acute esophageal variceal sclerotherapy: Results of a prospective randomized trial, JAMA, 255, 497, 10.1001/jama.1986.03370040071026 Lebrec, 1994, Pharmacologic treatment of portal hypertension: Hemodynamic effects and prevention of bleeding, Pharmacol Ther, 61, 65, 10.1016/0163-7258(94)90059-0 Lebrec, 1982, The effect of propranolol on portal hypertension in patients with cirrhosis: A hemodynamic study, Hepatology, 2, 523, 10.1002/hep.1840020502 Lebrec, 1984, A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A final report, Hepatology, 4, 355, 10.1002/hep.1840040301 Lebrec, 1988, Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis, a randomized trial, J Hepatol, 7, 118, 10.1016/S0168-8278(88)80515-4 Leung, 1997, Large paraesophageal varices on endosonography predict recurrence of esophageal varices and rebleeding, Gastroenterology, 112, 1811, 10.1053/gast.1997.v112.pm9178670 Lo, 1994, Endoscopic injection sclerotherapy vs. endoscopic variceal ligation in arresting acute variceal bleeding for patients with advanced hepatocellular carcinoma, J Hepatol, 21, 1048, 10.1016/S0168-8278(05)80616-6 Lo, 1997, Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices, Hepatology, 25, 1101, 10.1002/hep.510250509 Loperfido, 1987, [Somatostatin in the treatment of hemorrhaging esophago-gastric varices, Controlled clinical trial in comparison with ranitidine.] Recenti Prog Med, 78, 82 Lundell, 1990, Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions, Acta Chir Scand, 156, 711 Mackowiak, 1982, The normal microbial flora, N Engl J Med, 307, 83, 10.1056/NEJM198207083070203 Marbet, 1988, Reduction in early recurrence of variceal bleeding by propranolol, Scand J Gastroenterol, 23, 369, 10.3109/00365528809093881 Marteau, 1988, Effect of vasolidators on hepatic microcirculation: A study of the inhibition of norepinephrine-induced vasoconstriction in the isolated perfused rat liver, Hepatology, 8, 228, 10.1002/hep.1840080206 Martin, 1991, Prevention des recidives hemorragiques chez des malades atteints de cirrhose. Resultats d'une etude controlee comparant propranolol et sclerose endoscopique, Gastroenterol Clin Biol, 15, 833 Mastai, 1987, Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis, J Hepatol, 4, 71, 10.1016/S0168-8278(87)80012-0 McCormick, 1990, How to insert a Sengstaken-Blakemore tube, Br J Hosp Med, 43, 274 McCormick, 1994, Propranolol and isosorbide mononitrate versus sclerotherapy or shunt surgery for the prevention of variceal rebleeding: A randomized trial [abstract], Hepatology, 20, 106A McKee, 1990, A study of octreotide in oesophageal varices, Digestion, 45, 60, 10.1159/000200264 Merkel, 1987, Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis, J Hepatol, 4, 174, 10.1016/S0168-8278(87)80077-6 Merkel, 1996, Randomized trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale, Lancet, 348, 1677, 10.1016/S0140-6736(96)05406-2 Michielsen, 1994, Haemodynamic changes in portal hypertension: New insights in the pathogenesis and clinical implications, Acta Gastroenterol Belg, 57, 194 Moreau, 1989, Low dose of nitroglycerin failed to improve splanchnic hemodynamics in patients with cirrhosis: Evidence for an impaired cardiopulmonary baroreflex function, Hepatology, 10, 93, 10.1002/hep.1840100118 Moreto, 1988, A randomized trial of tamponade or sclerotherapy as immediate treatment for bleeding esophageal varices, Surgery Gynecology and Obstetrics, 167, 331 Morillas, 1994, Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: Long-term hemodynamic and renal effects, Hepatology, 20, 1502, 10.1002/hep.1840200620 Mountokalakis, 1988, Enhancement of renal function by a long-acting somatostatin analogue in patients with decompensated cirrhosis, Nephrol Dial Transplant, 3, 604, 10.1093/oxfordjournals.ndt.a091713 Nace, 1987, Pharmacokinetics of long-acting propranolol: Implications for therapeutic use, Clin Pharmacokinet, 13, 51, 10.2165/00003088-198713010-00003 Nagamine, 1996, The usefulness of ultrasonic microprobe imaging for endoscopic variceal ligation, Am J Gastroenterol, 91, 523 Navasa, 1989, Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function, Gastroenterology, 96, 1110, 10.1016/0016-5085(89)91630-2 Needleman, 1980, Vasodilators and the treatment of angina, 819 Nevens, 1998, Variceal pressure is a factor predicting the risk of a first variceal bleeding: A prospective cohort study in cirrhotic subjects, Hepatology, 27, 15, 10.1002/hep.510270104 Nevens, 1994, The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis, J Hepatol, 20, 27, 10.1016/S0168-8278(05)80463-5 Nevens, 1996, Assessment of variceal pressure by continuous non-invasive endoscopic registration: A placebo controlled evaluation of the effect of terlipressin and octreotide, Gut, 38, 129, 10.1136/gut.38.1.129 Novella, 1996, Octreotides. sclerotherapy and octreotide for acute variceal bleeding Pilot study, Hepatology, 24, 207A Nozue, 1995, Plasma endothelin-1 levels of children with cirrhosis, J Pediatr Gastroenterol Nutr, 21, 220, 10.1097/00005176-199508000-00015 Ohnishi, 1985, Effects of propranolol on portal hemodynamics in patients with chronic liver disease, Am J Gastroenterol, 80, 132 Ortiz, 1997, Somatostatin alone or combined with emergency sclerotherapy for acute variceal bleeding [abstract], Gastrointest Endosc, 45, AB77, 10.1016/S0016-5107(97)80206-4 Pagliaro, 1989, Therapeutic controversies and randomized controlled trials: Prevention of bleeding and rebleeding in cirrhosis, Gastroenterol Int, 2, 71 Pagliaro, 1994, Portal hypertension in cirrhosis: Natural history, 72 Pagliaro, 1992, Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment, Ann Intern Med, 117, 59, 10.7326/0003-4819-117-1-59 Panes, 1988, Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices, Dig Dis Sci, 33, 454, 10.1007/BF01536031 Paquet, 1985, Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: A prospective controlled randomized trial, Hepatology, 5, 580, 10.1002/hep.1840050409 Paquet, 1988, Immediate endoscopic sclerosis of bleeding gastroesophageal varices: A prospective evaluation over 5 years, Surg Endosc, 1, 18, 10.1007/BF00591393 Pascal, 1988, Propranolol in the prevention of first upper gastrointestinal hemorrhage in patients with cirrhosis of the liver and esophageal varices, N Engl J Med, 317, 856, 10.1056/NEJM198710013171403 Pauwels, 1994, [Terlipressin and somatostatin in the treatment of hemorrhages from rupture of esophageal varices (letter)], Gastroenterol Clin Biol, 18, 388 Perez-Ayuso, 1991, Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis, Lancet, 337, 1431, 10.1016/0140-6736(91)93125-S Planas, 1994, A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding, Hepatology, 20, 370, 10.1002/hep.1840200216 Polio, 1986, Hemodynamic factors involved in the development and rupture of esophageal varices: A pathophysiologic approach to treatment, Semin Liver Dis, 6, 318, 10.1055/s-2008-1040614 Pomier Layrargues, 1987, Systemic and hepatic hemodynamics after variceal hemorrhage: Effects of propranolol and placebo, Gastroenterology, 93, 1218, 10.1016/0016-5085(87)90247-2 Poynard, 1987, Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A prospective study of factors associated with rebleeding, Hepatology, 7, 447, 10.1002/hep.1840070306 Prandi, 1976, Life-threatening hemorrhage of the digestive tract in cirrhotic patients, Am J Surg, 131, 204, 10.1016/0002-9610(76)90098-2 Primignani, 1995, Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic Club, Hepatology, 21, 1322, 10.1016/0270-9139(95)90054-3 Queneit, 1987, Etude controlee du propranolol dans la prevention des recidives hemorrhagiques chez des patients cirrhotiques, Gastroenterol Clin Biol, 11, 41 Qureshi, 1990, Efficacy of oral propranolol and injection sclerotherapy in the long-term management of variceal bleeding, Digestion, 46, 193, 10.1159/000200345 Rector, 1990, Nitroglycerin for portal hypertension. A controlled comparison of the hemodynamic effects of graded doses, J Hepatol, 10, 375, 10.1016/0168-8278(90)90150-P Reichlin, 1983, Somatostatin (part I), N Engl J Med, 309, 1495, 10.1056/NEJM198312153092406 Rockey, 1996, Modulation of nitric oxide synthase III in sinusoidal endothelial cells: Implications for the pathogenesis of portal hypertension, Hepatology, 24, 190A Rockey, 1998, Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension, Gastroenterology, 114, 344, 10.1016/S0016-5085(98)70487-1 Rodes, 1996, The evolution of knowledge on the pathophysiology of portal hypertension, 18 Rodriguez-Perez, 1992, Pharmacologic treatment of portal hypertension, Gastroenterol Clin North Am, 21, 15, 10.1016/S0889-8553(21)00176-X Rossi, 1991, Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: Prospective controlled trial of propranolol and sclerotherapy, J Hepatol, 12, 283, 10.1016/0168-8278(91)90828-Y Runyon, 1994, Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis, J Hepatol, 21, 792, 10.1016/S0168-8278(94)80241-6 Sacerdoti, 1991, Importance of 1 month effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis, J Hepatol, 12, 124, 10.1016/0168-8278(91)90921-W Saeed, 1996, The Saeed six-shooter: A prospective study of a new endoscopic multiple rubber-band ligator for the treatment of varices, Endoscopy, 28, 559, 10.1055/s-2007-1005555 Saeed, 1990, Endoscopic variceal ligation in patients who have failed endoscopic sclerotherapy, Gastrointest Endosc, 36, 572, 10.1016/S0016-5107(90)71166-2 Salmeron, 1991, Isosorbide-5-mononitrate (ISMN) increases plama renin activity (PRA) and aldosterone (ALD) and impairs renal function in cirrhosis and ascites, J Hepatol, 13, S67, 10.1016/0168-8278(91)91258-I Sanowski, 1987, Endoscopic techniques and complications in variceal sclerotherapy, J Clin Gastroenterol, 9, 504, 10.1097/00004836-198710000-00003 Sanyal, 1996, Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy, Gastroenterology, 111, 138, 10.1053/gast.1996.v111.pm8698192 Sanyal, 1993, Transjugular intrahepatic portosystemic shunt (TIPS) for uncontrolled variceal hemorrhage in advanced cirrhotics at high-risk for surgery: A prospective study [abstract], Gastroenterology, 104, A985 Sarin, 1989, Endoscopic sclerotherapy for esophago-gastric varices: A critical reappraisal, Aust N Z J Med, 19, 162, 10.1111/j.1445-5994.1989.tb00234.x Sarin, 1997, Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: Influence on gastropathy, gastric varices and variceal recurrence, J Hepatol, 26, 826, 10.1016/S0168-8278(97)80248-6 Sarin, 1996, A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding [see comments], Eur J Gastroenterol Hepatol, 8, 337, 10.1097/00042737-199604000-00010 Sarin, 1986, Comparison of the two time schedules for endoscopic sclerotherapy: A prospective randomised controlled study, Gut, 27, 710, 10.1136/gut.27.6.710 Scarpignato, 1992, Clinical pharmacology of active variceal bleeding, Dig Dis, 10, 16, 10.1159/000171384 Schmid, 1984, Vasopressin and oxytocin in the neural control of circulation, Federation Proceedings, 43, 97 Sheen, 1989, Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis, Liver, 9, 1, 10.1111/j.1600-0676.1989.tb00370.x Shields, 1992, A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices, J Hepatol, 16, 128, 10.1016/S0168-8278(05)80105-9 Sieber, 1993, [Pathophysiological and pharmacotherapeutic aspects of portal hypertension.], Schweiz Med Wochenschr, 123, 3 Signorelli, 1996, Sclerotherapy with and without somatostatin or octreotide in the treatment of acute variceal hemoeehage, Gastroenterology, 110, A1326 Smith, 1982, Variceal hemorrhage: A critical evaluation of survival analysis, Gastroenterology, 82, 968, 10.1016/S0016-5085(82)80264-3 Snady, 1987, The role of sclerotherapy in the treatment of esophageal varices: Personal experience and a review of randomized trials, Am J Gastroenterol, 82, 813 Soderlund, 1985, Endoscopic sclerotherapy of oesophageal varices. A clinical study, Acta Chir. Scand, 524, 1 Soderlund, 1985, Endoscopic sclerotherapy v. conservative management of bleeding oesophageal varices. A 5-year prospective controlled trial of emergency and long-term treatment, Acta Chirugica Scandinavica, 151, 449 Soderlund, 1985, Endoscopic sclerotherapy vs conservative management of bleeding oesophageal varices, Acta Chirugica Scandinavica, 151, 449 Sonnenberg, 1981, Effect of somatostatin on splanchnic hemodynamics, Gastroenterology, 80, 526, 10.1016/0016-5085(81)90015-9 Stiegmann, 1988, Endoscopic esophageal varix ligation: Preliminary clinical experience, Gastrointest Endosc, 34, 113, 10.1016/S0016-5107(88)71274-2 Stiegmann, 1992, Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices, N Engl J Med, 326, 1527, 10.1056/NEJM199206043262304 Sung, 1993, Octreotide infusion or emergency sclerotherapy for variceal haemorrhage [see comments], Lancet, 342, 637, 10.1016/0140-6736(93)91758-E Sung, 1995, Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation, Lancet, 346, 1666, 10.1016/S0140-6736(95)92840-5 Svoboda, 1999, A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices, Surg Endosc, 13, 580, 10.1007/s004649901045 Terblanche, 1983, Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding, Lancet, 2, 1328, 10.1016/S0140-6736(83)91090-5 Teres, 1993, Propranolol versus sclerotherapy in preventing variceal rebleeding; a randomized controlled trial, Gastroenterology, 105, 1508, 10.1016/0016-5085(93)90158-9 Teres, 1978, Esophageal tamponade for bleeding varices, Gastroenterology, 75, 566, 10.1016/S0016-5085(19)31660-9 The Copenhagen Esophageal Varices Sclerotherapy Project, 1984, Sclerotherapy after first variceal hemorrhage in cirrhosis, N Engl J Med, 311, 1594, 10.1056/NEJM198412203112502 The PROVA study group, 1991, Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: A randomized multicenter trial, Hepatology, 14, 1016, 10.1002/hep.1840140612 Tsai, 1986, Controlled trial of vasopressin plus nitroglycerin vs vasopressin alone in the treatment of bleeding esophageal varices, Hepatology, 6, 406, 10.1002/hep.1840060313 Tsai, 1991, Hyposensitivity to vasopressin in patients with hepatitis-B related cirrhosis during acute hemorrhage from esophageal varices, Hepatology, 13, 407 Tsai, 1989, Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis, Hepatology, 10, 283, 10.1002/hep.1840100305 Tyden, 1979, Circulatory effects of somatostatin in anesthetized man, Acta Chirugica Scandinavica, 145, 443 Valenzuela, 1989, A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices, Hepatology, 10, 958, 10.1002/hep.1840100611 Valla, 1987, Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol, J Hepatol, 5, 144, 10.1016/S0168-8278(87)80565-2 Variceal Bleeding Study Group, 1994, Glypressin vs somatostatin in the treatment of acute variceal bleeding in patients with cirrhosis: A double-blind randomized controlled trial [abstract], Hepatology, 19, 1361A Viallet, 1975, Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the porto-hepatic gradient, Gastroenterology, 69, 1297 Vickers, 1987, Prospective controlled trial of propranolol and sclerotherapy for prevention of rebleeding from oesophageal varices [abstract], Gut, 28, A1359 Villanueva, 1996, Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding, N Engl J Med, 334, 1624, 10.1056/NEJM199606203342502 Villeneuve, 1986, Propranolol for the prevention of recurrent variceal hemorrhage: A controlled study, Hepatology, 6, 1239, 10.1002/hep.1840060602 Vinel, 1992, Propranolol reduced the rebleeding rate during endoscopic sclerotherapy before variceal obliteration, Gastroenterology, 102, 1760, 10.1016/0016-5085(92)91740-U Vorobioff, 1987, Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients, Hepatology, 7, 648, 10.1002/hep.1840070406 Waked, 1997, Analysis of long-term endoscopic surveillance during follow-up after variceal sclerotherapy from a 13-year experience, Am J Med, 102, 192, 10.1016/S0002-9343(96)00401-9 Waldman, 1987, Cyclic GMP synthesis and function, Pharmacol Rev, 39, 163 Walker, 1992, Terlipressin vs. somatostatin in bleeding esophageal varices: A controlled, double-blind study, Hepatology, 15, 1023, 10.1002/hep.1840150609 Walker, 1986, Terlipressin in bleeding esophageal varices: A placebo-controlled, double-blind study, Hepatology, 6, 112, 10.1002/hep.1840060121 Westaby, 1984, Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension, Gut, 25, 121, 10.1136/gut.25.2.121 Westaby, 1989, Controlled clinical trial of injection sclerotherapy for active variceal bleeding, Hepatology, 9, 274, 10.1002/hep.1840090219 Westaby, 1985, Improved survival following injection sclerotherapy for esophageal varices: Final analysis of a controlled trial, Hepatology, 5, 827, 10.1002/hep.1840050520 Westaby, 1986, Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration, Hepatology, 6, 673, 10.1002/hep.1840060422 Westaby, 1984, Injection sclerotherapy for oesophageal varices: A prospective randomised trial of different treatment schedules, Gut, 25, 129, 10.1136/gut.25.2.129 Westaby, 1990, A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding, Hepatology, 11, 353, 10.1002/hep.1840110304 Young, 1993, Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy [see comments], Gastrointest Endosc, 39, 119, 10.1016/S0016-5107(93)70049-8 Zoli, 1986, Portal venous flow in response to acute β blocker and vasodilatory treatment in patients with liver cirrhosis, Hepatology, 6, 1248, 10.1002/hep.1840060604